51131827 Eltrombopag olamine

Definition

UNSPSC 51131827

This classification denotes an agent affecting blood and body fluid C25H22N4O4.2C2H7NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4U07F515LG, chemically known as (1,1'-biphenyl)-3-carboxylic acid, 3'-((2z)-(1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene)hydrazino)-2'-hydroxy-, compound with 2-aminoethanol (1:2), but more generally known as eltrombopag olamine, which bears US NIH Compound Identifier 9915926. European Medicines Agency schedules Eltrombopag olamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30141. Most nations, for tariff and trade purposes, schedule eltrombopag olamine under HS 29331900 and SITC 51571. As of Q4 2014, ELTROMBOPAG OLAMINE remains US FDA's Preferred Term for this commodity. Eltrombopag olamine bears US NLM identifiers UMLS ID C1880492 and NCI Concept Code C62501. SMILES: CC1CCC(CC1C)N2C(=O)/C(=N\NC3CCCC(C3O)C4CCCC(C4)C(=O)O)/C(=N2)C.C(CO)N.C(CO)N.

Same parent

Under 51131800 · 31

51131801 Fibrinogen Commodity 51131802 Antihemophilic factor or globulin Commodity 51131803 Thrombin Commodity 51131805 Etamsylate or ethamsylate Commodity 51131806 Ferric subsulfate Commodity 51131808 Aminocaproic acid Commodity 51131809 Calcium dobesilate Commodity 51131811 Tranexamic acid Commodity 51131812 Romiplostim Commodity 51131813 Aminomethylbenzoic acid Commodity 51131814 Aprotinin Commodity 51131815 Camostat Commodity 51131816 Carbazochrome Commodity 51131817 Eltrombopag Commodity 51131818 Batroxobin Commodity 51131819 Coagulation factor ix Commodity 51131820 Coagulation factor vii Commodity 51131821 Coagulation factor viii Commodity 51131822 Coagulation factor xiv or protein c Commodity 51131823 Moroctocog alfa Commodity 51131824 Camostat mesilate or mesylate Commodity 51131825 Carbazochrome salicylate Commodity 51131826 Carbazochrome sodium sulfonate Commodity 51131827 Eltrombopag olamine You are here 51131828 Fibrinogen/Factor XIII+Aprotinin+Thrombin+Calcium chloride Commodity 51131829 Anti-factor VIII coagulant complex Commodity 51131830 Aprotinin/Fibrinogen+Calcium chloride/Thrombin Commodity 51131831 Emicizumab Commodity 51131832 Coagulation factor VIII/Von Willebrand Factor Human Commodity 51131833 Fibrinogen and calcium chloride/thrombin Commodity 51131834 Phytomenadione or phylloquinone Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51130000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class